Summit Financial Strategies, Inc. Abb Vie Inc. Transaction History

Summit Financial Strategies, Inc.

$821 Million
Q3 2024

A detailed history of Summit Financial Strategies, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Summit Financial Strategies, Inc. holds 5,016 shares of ABBV stock, worth $902,880. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,016

Previous 5,087 1.4%

Holding current value

$902,880

Previous $872,000 13.53%

% of portfolio

0.12%

Previous 0.12%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $11,632 - $14,152	-71 Reduced 1.4%	5,016 $990,000
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $2,786 - $3,253	-18 Reduced 0.35%	5,087 $872,000
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $182,834 - $208,322	-1,144 Reduced 18.31%	5,105 $929,000
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $19,264 - $21,695	-140 Reduced 2.19%	6,249 $968,000
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $34,199 - $39,590	-256 Reduced 3.85%	6,389 $952,000
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $5,432 - $6,760	41 Added 0.62%	6,645 $895,000
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $4,482 - $5,162	-31 Reduced 0.47%	6,604 $1.05 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $38,311 - $45,945	-277 Reduced 4.01%	6,635 $0
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $36,102 - $41,407	269 Added 4.05%	6,912 $928,000
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $48,442 - $61,585	352 Added 5.6%	6,643 $1.02 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $72,193 - $89,571	-547 Reduced 8.0%	6,291 $1.02 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $281,015 - $313,067	2,671 Added 64.1%	6,838 $770,000
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $93,297 - $102,709	-912 Reduced 17.96%	4,167 $451,000
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $39,279 - $53,030	-488 Reduced 8.77%	5,079 $544,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $343 - $403	4 Added 0.07%	5,567 $488,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $27,146 - $36,326	370 Added 7.12%	5,563 $546,000
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $22,575 - $34,226	-350 Reduced 6.31%	5,193 $396,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $4,760 - $5,956	66 Added 1.21%	5,543 $491,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $39,425 - $47,400	-626 Reduced 10.26%	5,477 $415,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $10,971 - $14,024	-167 Reduced 2.66%	6,103 $444,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $1,157 - $1,361	-15 Reduced 0.24%	6,270 $505,000
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $223,253 - $248,187	-2,511 Reduced 28.55%	6,285 $594,000
Q2 2018 Aug 06, 2018	BUY	$89.78 - $106.23 $300,403 - $355,445	3,346 Added 61.39%	8,796 $815,000
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $154,116 - $206,376	1,675 Added 44.37%	5,450 $516,000
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $263,683 - $336,805	3,775	3,775 $335,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Strategies, Inc. with notifications on news.

Account

Summit Financial Strategies, Inc. Abb Vie Inc. Transaction History